James Basta Sells $16.7K of Intellia Therapeutics Inc (NTLA) — SEC Form 4, Mar 03, 2026
Open-Market Net Sale · SEC Form 4
−$16,688
Equity position changed by +39.7%
Equity Position
158K sh
113,136 → 158,005
Equity Change
+39.7%
shares held after vs before
Filing Lag
1 business day
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| James Basta CIK 0001792726 |
GC
|
James Basta at Intellia Therapeutics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$112,444
More from this insider at Intellia Therapeutics Inc
| 2026-01-07 | Sell | -$95,756 | View |
| 2025-03-04 | Sell | -$23,122 | View |
| 2025-01-07 | Sell | -$86,161 | View |
| 2024-03-05 | Sell | -$75,778 | View |
| 2024-01-05 | Sell | -$112,095 | View |
Non-Derivative Securities Transactions
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $13.78 | 2026-03-01 | A - Award/Grant | 65,829 A | $0.00 | 2036-02-29 | 65,829 Common Stock | Direct |
Footnotes (3)
- F1
- Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit Show more
- F2
- Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on March 1, 2026, and does not represent a volitional trade by the Reporting Person. Show more
- F3
- This option was granted on March 1, 2026 with respect to shares of Common Stock, with 33% vesting on January 1, 2027 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter. Show more
Related filings at Intellia Therapeutics Inc
Institutional Holders
13F holders · Jun 30, 2026
328
institutional managers reporting a position
Largest by reported value
- Ark Investment Management Llc $286M
- Black Rock, Inc. $261M
- State Street Corporation $156M
5%+ Holders · 13D/G
5 filers
Other insiders at Intellia Therapeutics Inc
-
John M Leonard -$108K
-
Michael P Dube -$23.2K
-
John M Leonard -$287K
-
Edward J Dulac III -$91.2K
GET /v1/forms/4/0001193125-26-088260
API docs
View Original SEC Filing